SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MRE (medco research)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sam who wrote (109)8/3/1998 10:48:00 AM
From: Harold V  Read Replies (2) of 192
 
Sam, Even if slightly underestimated, you still made a great call on MRE's prospective earnings. Did you get the package of materials on MRE that included the interview of Roger Blevins in Investor's Bus. Daily and MRE's letter re the report of half year accomplishments? Very Impressive. While I've sold some of my MRE holdings over the last several weeks, I'm planning to hold on to my remaining shares as MRE makes its transition from receiving commissions for outsourcing its sales to directly selling its products. But should MRE get an FDA approval for using adenosine during angeoplasty, I'll be hoping to accumulate more shares because the company's earnings should explode well beyond the solid bottom-line growth we've been seeing. I'd greatly appreciate your sharing some of you thoughts and plans--publically or privately. Thanks in advance, Harold V
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News